Abstract: A method of selecting a braid configuration for a braided liner. The method includes calculating a size ratio based on the smallest first diameter and the largest second diameter of the liner and selecting a braid material having a tensile strength. The method further includes calculating a strength ratio based on the tensile strength of the braid material and a selected target strength threshold for the braided liner and determining an optimal braid angle for the smallest first diameter portions of the liner based on the calculated size ratio.

Abstract: The present disclosure is directed, at least in part, to disease-modifying treatments for neurodegenerative disorders. In one embodiment, a method of delaying worsening of one or more symptoms and/or progression of a neurodegenerative disorder is provided. In one embodiment, a method of treating or ameliorating one or more symptoms of a neurodegenerative disorder is provided. In one embodiment, the methods of the present invention comprise administering to a subject in need thereof, a compound having the structure of Formula (1a); Formula (1a); and/or a pharmaceutically acceptable salt thereof. In one embodiment, the the compound of (1a) and/or a pharmaceutically acceptable salt thereof is administered in combination with one or more pharmacologically active agents.

Abstract: A method of making a tank for storing fluid that includes generating a resinated braid layer on an elongated liner having a plurality of successively alternating rigid and flexible portions along the length of the liner. Generating the resinated braid layer on the liner includes feeding the liner into a braiding machine and applying resin to a plurality of fibers during a braiding process to generate a resinated plurality of fibers and generating, over a length of the liner, by the braiding machine, the resinated braid layer defined by the resinated plurality of fibers.

Abstract: The present disclosure is directed, at least in part, to disease-modifying treatments for neurodegenerative disorders. In one embodiment, a method of delaying worsening of one or more symptoms and/or progression of a neurodegenerative disorder is provided. In one embodiment, a method of treating or ameliorating one or more symptoms of a neurodegenerative disorder is provided. In one embodiment, the methods of the present invention comprise administering to a subject in need thereof, a compound having the structure of Formula (1a):Formula (1a); and/or a pharmaceutically acceptable salt thereof. In one embodiment, the the compound of (1a) and/or a pharmaceutically acceptable salt thereof is administered in combination with one or more pharmacologic ally active agents.

Abstract: Disclosed herein are PVP-I-containing compositions, as well as methods of making such compositions, which provide reliable stability for PVP-I preparations, including preparations comprising PVP-I and one or more additional components.

Abstract: Disclosed are stable compositions comprising povidone-iodine and a steroid, and methods of making and using such compositions. Also disclosed herein are stable compositions comprising povidone-iodine and an NSAID, and methods of making and using such compositions.

Abstract: The present application provides a subscription interface positioned between client devices and third-party digital subscription providers. The subscription interface allows multiple different publication-related applications (e.g., Sports Illustrated, Time magazine, etc.) running on different client devices (e.g., tablets, desktop computers, laptop computers, smart phones, etc.) to obtain a list of digital issues available from an associated third-party digital subscription provider based on entitlements of the user of the client device. The subscription interface ensures that the application receives the list and associated metadata in a desired format for that particular application on a particular client device.

Abstract: Systems, methods, and computer-program products identify clinical data corresponding to a plurality of patients located within a common health care delivery unit, and apply one or more rules to at least some of the clinical data using at least one quality and/or safety measure-specific specification. Based on the application of the rules, one or more care indicators corresponding to the plurality of patients are displayed in a single interface, the one or more care indicators indicating whether one or more of the patients is receiving appropriate care.

Abstract: A system and method for screening telephone calls to a subscriber telephone number comprises a screening list of telephone numbers assigned to suspect callers and rules defining when a telephone number will be added to or removed from the screening list or ‘greylist,’ and/or modifying a screening value to be assigned to a telephone number in the greylist. Data relating to calls is received from subscribers and processed, and the telephone number is screened in accordance with the rules, based on the screening value assigned to the telephone number and optionally a selected subscriber tolerance level. Subscribers may add any telephone number to a personal list of telephone numbers to be blocked (blacklist) or telephone numbers to be accepted (whitelist).

Abstract: The invention includes a preserved ophthalmic preparation comprising povidone-iodine (PVP-I) at a concentration sufficient to preserve the ophthalmic preparation, and at least one member selected from the group consisting of a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial compound, an anti-allergy compound, and an anti-glaucoma compound. The invention also includes adding PVP-I to an ophthalmic composition in order to preserve the composition, wherein the PVP-I is added at a concentration sufficient to preserve the composition.

Abstract: Disclosed are compositions and methods comprising povidone-iodine and a cooling-effective amount of a chemical agent. The compositions are useful to relieve mild ocular irritation, enhance ocular comfort, and to provide a refreshing effect and improved sensation, when the povidone-iodine solution is applied to the eye.

Abstract: Disclosed herein compositions including povidone-iodine (PVP-I) useful in the treatment of acute and chronic bacterial, viral and fungal infections of the internal, middle and external ear of mammals, including humans.

Abstract: The present application provides a subscription interface positioned between client devices and third-party digital subscription providers. The subscription interface allows multiple different publication-related applications (e.g., Sports Illustrated, Time magazine, etc.) running on different client devices (e.g., tablets, desktop computers, laptop computers, smart phones, etc.) to obtain a list of digital issues available from an associated third-party digital subscription provider based on entitlements of the user of the client device. The subscription interface ensures that the application receives the list and associated metadata in a desired format for that particular application on a particular client device.

Abstract: A system and method for screening incoming communications to a subscriber telephone number comprises a screening list of telephone numbers assigned to suspect incoming communication originators and rules defining when a telephone number will be added to or removed from the screening list or ‘greylist,’ and/or modifying a screening value to be assigned to a telephone number in the greylist. Data relating to an incoming communication is received from subscribers and processed, and the telephone number is screened in accordance with the rules, based on the screening value assigned to the telephone number and optionally a selected subscriber tolerance level. Subscribers may add any telephone number to a personal list of telephone numbers to be blocked (blacklist) or telephone numbers to be accepted (whitelist).

Abstract: The invention includes a preserved ophthalmic preparation comprising povidone-iodine (PVP-I) at a concentration sufficient to preserve the ophthalmic preparation, and at least one member selected from the group consisting of a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial compound, an anti-allergy compound, and an anti-glaucoma compound. The invention also includes adding PVP-I to an ophthalmic composition in order to preserve the composition, wherein the PVP-I is added at a concentration sufficient to preserve the composition.

Abstract: Systems, methods, and computer-program products identify clinical data corresponding to a plurality of patients located within a common health care delivery unit, and apply one or more rules to at least some of the clinical data using at least one quality and/or safety measure-specific specification. Based on the application of the rules, one or more care indicators corresponding to the plurality of patients are displayed in a single interface, the one or more care indicators indicating whether one or more of the patients is receiving appropriate care.

Abstract: Disclosed herein compositions including povidone-iodine (PVP-I) useful in the treatment of acute and chronic bacterial, viral and fungal infections of the internal, middle and external ear of mammals, including humans.

Abstract: A system and method for screening telephone calls to a subscriber telephone number comprises a screening list of telephone numbers assigned to suspect callers and rules defining when a telephone number will be added to or removed from the screening list or ‘greylist,’ and/or modifying a screening value to be assigned to a telephone number in the greylist. Data relating to calls is received from subscribers and processed, and the telephone number is screened in accordance with the rules, based on the screening value assigned to the telephone number and optionally a selected subscriber tolerance level. Subscribers may add any telephone number to a personal list of telephone numbers to be blocked (blacklist) or telephone numbers to be accepted (whitelist).

Abstract: This invention relates to the identification of a nucleic acid molecule. In particular, this invention relates to a method of using an oligonucleotide designed to a variable region of a nucleic acid molecule to identify A nucleic acid molecule.

Abstract: Disclosed herein compositions including povidone-iodine (PVP-I) useful in the treatment of acute and chronic bacterial, viral and fungal infections of the internal, middle and external ear of mammals, including humans.